This piece looks at three speculative, high-upside stocks that could reward long-term patience: Joby Aviation, Curaleaf Holdings, and Pony AI. Each company sits in an emerging sector where execution, regulation, and scale will determine winners and losers. The tone is clear: these are not safe bets, but they might pay off dramatically for investors who can stomach volatility and hold for years.
Growth stocks often demand tolerance for pain before any gain appears, and that truth is loud with these names. Small positions let you participate without overexposure while you assess progress on technology, regulation, and revenue traction. If you pick one or all, plan to revisit your thesis as milestones are hit or missed.
Joby Aviation is an electric vertical takeoff and landing company aiming to launch air taxi services once regulators sign off. The business is already doing demo flights in cities like New York and San Francisco, which suggests it has moved beyond whiteboard designs toward real-world testing. That progress positions Joby as an early leader in eVTOL, but commercial certification and profitable operations remain future events, not guarantees.
On the balance sheet, Joby is burning cash while it scales development, with a large loss reported last year. Heavy upfront spending on prototypes, testing, and certification is typical for aerospace startups, and the company could face more cash needs before revenues ramp. For long-term buyers, the bet is that market share and first-mover advantages will eventually justify today’s losses.
Curaleaf Holdings stands out on this list as the most established operator, producing and selling cannabis products across multiple state markets. The company reported positive operating income recently on revenue near the billion-dollar mark, which is rare among pure-play cannabis names. Its valuation remains modest relative to the potential if federal policy shifts toward broader legalization.
That regulatory backdrop is the crux of Curaleaf’s upside story: federal rescheduling of some marijuana products has sparked fresh optimism about larger reform. Still, investors should remember the industry’s history of hopeful headlines followed by delays, so timing and patience matter a lot. Buying in at a low valuation can work out, but it requires tolerance for policy-driven volatility.
Pony AI is a robotics and autonomous driving company that supplies software and hardware to convert vehicles into robotaxis and robotrucks. The firm has made notable international moves, including work that helped launch a robotaxi service in Europe, signaling real-world deployments beyond initial pilot zones. With a market cap that places it in the small-cap growth arena, Pony is still building scale and commercial traction.
Revenue growth at Pony AI has been strong year over year, yet the company remains unprofitable as it invests in hardware, software, and service rollouts. Rapid top-line expansion can coexist with heavy operating losses while a company chases scale, but that pattern raises the chance of dilution or the need for partners to accelerate deployment. The upside is substantial if autonomous ride services and licensing deals scale profitably, but the path is bumpy.
None of these stocks is a conservative pick: Joby and Pony are technology-first plays that require successful certification and commercialization, and Curaleaf hinges on legal and policy shifts plus execution. A sensible approach is small, staged stakes tied to clearly defined milestones such as certification timelines, revenue growth, or regulatory progress. Diversify across themes and set expectations that any 10x outcome is a multi-year story with lots of noise along the way.
*Stock Advisor returns as of June 2, 2026. Treat historical performance figures as context, not guarantees, and match any purchase to your personal risk tolerance and investment timeline.
